Allred Capital Management, LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 36 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Allred Capital Management, LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$41,862
+54.9%
466,688
+58.8%
0.02%
+61.5%
Q2 2023$27,033
-36.9%
293,838
+78.4%
0.01%
-43.5%
Q1 2023$42,832
+84.7%
164,738
+49.2%
0.02%
+76.9%
Q4 2022$23,192
+110.8%
110,438
+133.8%
0.01%
+85.7%
Q3 2022$11,000
-57.7%
47,238
+28.2%
0.01%
-56.2%
Q2 2022$26,000
-35.0%
36,838
-28.6%
0.02%
-23.8%
Q1 2022$40,000
-24.5%
51,622
-3.0%
0.02%
-19.2%
Q4 2021$53,000
-53.5%
53,238
-18.1%
0.03%
-56.7%
Q3 2021$114,000
-15.6%
64,988
-11.9%
0.06%
-10.4%
Q2 2021$135,000
-99.9%
73,788
+15.3%
0.07%
+15.5%
Q1 2021$129,286,000
+114312.4%
64,003
+20.9%
0.06%
-6.5%
Q4 2020$113,000
-35.8%
52,926
-19.0%
0.06%
-41.5%
Q3 2020$176,000
-34.6%
65,303
-4.6%
0.11%
-38.0%
Q2 2020$269,000
+1693.3%
68,466
+233.5%
0.17%
+1325.0%
Q1 2020$15,000
-100.0%
20,528
-14.9%
0.01%
-29.4%
Q4 2019$30,401,000
+379912.5%
24,128
+113.2%
0.02%
+240.0%
Q3 2019$8,000
-27.3%
11,318
-41.7%
0.01%
-16.7%
Q2 2019$11,00019,4180.01%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2020
NameSharesValueWeighting ↓
Allred Capital Management, LLC 52,926$113,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,940$236,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$22,0000.00%
Sowell Financial Services LLC 11,190$24,0000.00%
TWO SIGMA INVESTMENTS, LP 101,949$219,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 32,822$71,0000.00%
UBS Group AG 816$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$2,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders